Anna Brown

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more. No­vo Nordisk is in­vest­ing DKK 120

Fol­low­ing a block­buster 2024, Sam­sung Bi­o­log­ics is con­sid­er­ing build­ing a sixth man­u­fac­tur­ing fa­cil­i­ty to meet the ris­ing de­mand for bi­o­log­ics as it gears up to

Pri­vate in­vest­ment firm Bridgewest is com­bin­ing its Aus­tralia-based bi­o­log­ics CD­MO BioCi­na and its ster­ile in­jectable man­u­fac­tur­er No­vaCi­na in­to one com­pa­ny. The new CD­MO will con­tin­ue

In­di­an CD­MO Ara­gen Life Sci­ences has se­cured a $100 mil­lion in­vest­ment from Sin­ga­pore-head­quar­tered pri­vate eq­ui­ty firm Quadria Cap­i­tal. Ara­gen will use the in­vest­ment to ex­pand

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more. Sam­sung Bi­o­log­ics has Sign up to